Before they can be marketed through the network of authorised professionals, veterinary medicinal products are subject to a Marketing Authorisation (MA), as are human medicinal products.
It has been demonstrated that poultry farm in villages is a viable alternative source of income for rural households. The Newcastle disease constitutes a major obstacle to develop and maintain these farms; it is therefore important to combat this virus through preventive vaccination campaigns. Through a field approach, LAPROVET is actively involved against this disease […]
Follow all LAPROVET news on Facebook, Linkedin and Twitter!
Interview of Dr Guillaume REMOND, LAPROVET’s Managing Director, which describe the strategic positioning and vision of the company during the VIV Bangkok in March 2015
Manufacturing site of LAPROVET’s Trypanocidals (Securidium & Survidim).
A new award for LAPROVET’s performances in 2014! Read the article from « La Nouvelle République » newspaper published on 16/12/2014 in MEDIAS section.
To develop its global activities, especially in poultry farming, LAPROVET’s team was at the VIV gathering in Utrecht, May 19-22. Our well-decorated stand attracted many visitors interested in our products. During four days, we met our long-standing partners and discussed with them about our common activities. Many potential distributors also showed interest to work with […]